Global Vascular Endothelial Growth Factor B Market Growth 2025-2031
The global Vascular Endothelial Growth Factor B market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Vascular Endothelial Growth Factor B Industry Forecast” looks at past sales and reviews total world Vascular Endothelial Growth Factor B sales in 2024, providing a comprehensive analysis by region and market sector of projected Vascular Endothelial Growth Factor B sales for 2025 through 2031. With Vascular Endothelial Growth Factor B sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vascular Endothelial Growth Factor B industry.
This Insight Report provides a comprehensive analysis of the global Vascular Endothelial Growth Factor B landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vascular Endothelial Growth Factor B portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vascular Endothelial Growth Factor B market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vascular Endothelial Growth Factor B and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vascular Endothelial Growth Factor B.
This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Endothelial Growth Factor B market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Vascular Endothelial Growth Factor B market?
What factors are driving Vascular Endothelial Growth Factor B market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vascular Endothelial Growth Factor B market opportunities vary by end market size?
How does Vascular Endothelial Growth Factor B break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Vascular Endothelial Growth Factor B Industry Forecast” looks at past sales and reviews total world Vascular Endothelial Growth Factor B sales in 2024, providing a comprehensive analysis by region and market sector of projected Vascular Endothelial Growth Factor B sales for 2025 through 2031. With Vascular Endothelial Growth Factor B sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vascular Endothelial Growth Factor B industry.
This Insight Report provides a comprehensive analysis of the global Vascular Endothelial Growth Factor B landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vascular Endothelial Growth Factor B portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vascular Endothelial Growth Factor B market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vascular Endothelial Growth Factor B and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vascular Endothelial Growth Factor B.
This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Endothelial Growth Factor B market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Aflibercept
- Aflibercept Biosimilar
- CSL-346
- Others
- Rectal Cancer
- Retinal Vein Occlusion
- Diabetic Nephropathy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alteogen Inc
- CSL Ltd
- Eli Lilly and Company
- Formycon AG
- Regeneron Pharmaceuticals Inc
What is the 10-year outlook for the global Vascular Endothelial Growth Factor B market?
What factors are driving Vascular Endothelial Growth Factor B market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vascular Endothelial Growth Factor B market opportunities vary by end market size?
How does Vascular Endothelial Growth Factor B break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transmucosal Drug Delivery Market Size (2020-2031)
2.1.2 Transmucosal Drug Delivery Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Transmucosal Drug Delivery by Country/Region (2020, 2024 & 2031)
2.2 Transmucosal Drug Delivery Segment by Type
2.2.1 Passive Transdermal Drug Delivery
2.2.2 Active Transdermal Drug Delivery
2.3 Transmucosal Drug Delivery Market Size by Type
2.3.1 Transmucosal Drug Delivery Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Transmucosal Drug Delivery Market Size Market Share by Type (2020-2025)
2.4 Transmucosal Drug Delivery Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Transmucosal Drug Delivery Market Size by Application
2.5.1 Transmucosal Drug Delivery Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Transmucosal Drug Delivery Market Size Market Share by Application (2020-2025)
3 TRANSMUCOSAL DRUG DELIVERY MARKET SIZE BY PLAYER
3.1 Transmucosal Drug Delivery Market Size Market Share by Player
3.1.1 Global Transmucosal Drug Delivery Revenue by Player (2020-2025)
3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Player (2020-2025)
3.2 Global Transmucosal Drug Delivery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TRANSMUCOSAL DRUG DELIVERY BY REGION
4.1 Transmucosal Drug Delivery Market Size by Region (2020-2025)
4.2 Global Transmucosal Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transmucosal Drug Delivery Market Size Growth (2020-2025)
4.4 APAC Transmucosal Drug Delivery Market Size Growth (2020-2025)
4.5 Europe Transmucosal Drug Delivery Market Size Growth (2020-2025)
4.6 Middle East & Africa Transmucosal Drug Delivery Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Transmucosal Drug Delivery Market Size by Country (2020-2025)
5.2 Americas Transmucosal Drug Delivery Market Size by Type (2020-2025)
5.3 Americas Transmucosal Drug Delivery Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transmucosal Drug Delivery Market Size by Region (2020-2025)
6.2 APAC Transmucosal Drug Delivery Market Size by Type (2020-2025)
6.3 APAC Transmucosal Drug Delivery Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Transmucosal Drug Delivery Market Size by Country (2020-2025)
7.2 Europe Transmucosal Drug Delivery Market Size by Type (2020-2025)
7.3 Europe Transmucosal Drug Delivery Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transmucosal Drug Delivery by Region (2020-2025)
8.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2020-2025)
8.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET FORECAST
10.1 Global Transmucosal Drug Delivery Forecast by Region (2026-2031)
10.1.1 Global Transmucosal Drug Delivery Forecast by Region (2026-2031)
10.1.2 Americas Transmucosal Drug Delivery Forecast
10.1.3 APAC Transmucosal Drug Delivery Forecast
10.1.4 Europe Transmucosal Drug Delivery Forecast
10.1.5 Middle East & Africa Transmucosal Drug Delivery Forecast
10.2 Americas Transmucosal Drug Delivery Forecast by Country (2026-2031)
10.2.1 United States Market Transmucosal Drug Delivery Forecast
10.2.2 Canada Market Transmucosal Drug Delivery Forecast
10.2.3 Mexico Market Transmucosal Drug Delivery Forecast
10.2.4 Brazil Market Transmucosal Drug Delivery Forecast
10.3 APAC Transmucosal Drug Delivery Forecast by Region (2026-2031)
10.3.1 China Transmucosal Drug Delivery Market Forecast
10.3.2 Japan Market Transmucosal Drug Delivery Forecast
10.3.3 Korea Market Transmucosal Drug Delivery Forecast
10.3.4 Southeast Asia Market Transmucosal Drug Delivery Forecast
10.3.5 India Market Transmucosal Drug Delivery Forecast
10.3.6 Australia Market Transmucosal Drug Delivery Forecast
10.4 Europe Transmucosal Drug Delivery Forecast by Country (2026-2031)
10.4.1 Germany Market Transmucosal Drug Delivery Forecast
10.4.2 France Market Transmucosal Drug Delivery Forecast
10.4.3 UK Market Transmucosal Drug Delivery Forecast
10.4.4 Italy Market Transmucosal Drug Delivery Forecast
10.4.5 Russia Market Transmucosal Drug Delivery Forecast
10.5 Middle East & Africa Transmucosal Drug Delivery Forecast by Region (2026-2031)
10.5.1 Egypt Market Transmucosal Drug Delivery Forecast
10.5.2 South Africa Market Transmucosal Drug Delivery Forecast
10.5.3 Israel Market Transmucosal Drug Delivery Forecast
10.5.4 Turkey Market Transmucosal Drug Delivery Forecast
10.6 Global Transmucosal Drug Delivery Forecast by Type (2026-2031)
10.7 Global Transmucosal Drug Delivery Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Transmucosal Drug Delivery Forecast
11 KEY PLAYERS ANALYSIS
11.1 3M Pharmaceuticals
11.1.1 3M Pharmaceuticals Company Information
11.1.2 3M Pharmaceuticals Transmucosal Drug Delivery Product Offered
11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 3M Pharmaceuticals Main Business Overview
11.1.5 3M Pharmaceuticals Latest Developments
11.2 Acrux Limited
11.2.1 Acrux Limited Company Information
11.2.2 Acrux Limited Transmucosal Drug Delivery Product Offered
11.2.3 Acrux Limited Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Acrux Limited Main Business Overview
11.2.5 Acrux Limited Latest Developments
11.3 ALZA Corporation
11.3.1 ALZA Corporation Company Information
11.3.2 ALZA Corporation Transmucosal Drug Delivery Product Offered
11.3.3 ALZA Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 ALZA Corporation Main Business Overview
11.3.5 ALZA Corporation Latest Developments
11.4 Antares Pharma, Inc.
11.4.1 Antares Pharma, Inc. Company Information
11.4.2 Antares Pharma, Inc. Transmucosal Drug Delivery Product Offered
11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Antares Pharma, Inc. Main Business Overview
11.4.5 Antares Pharma, Inc. Latest Developments
11.5 Apricus BioSciences, Inc
11.5.1 Apricus BioSciences, Inc Company Information
11.5.2 Apricus BioSciences, Inc Transmucosal Drug Delivery Product Offered
11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Apricus BioSciences, Inc Main Business Overview
11.5.5 Apricus BioSciences, Inc Latest Developments
11.6 Aveva Drug Delivery Systems
11.6.1 Aveva Drug Delivery Systems Company Information
11.6.2 Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Offered
11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Aveva Drug Delivery Systems Main Business Overview
11.6.5 Aveva Drug Delivery Systems Latest Developments
11.7 Corium International, Inc
11.7.1 Corium International, Inc Company Information
11.7.2 Corium International, Inc Transmucosal Drug Delivery Product Offered
11.7.3 Corium International, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Corium International, Inc Main Business Overview
11.7.5 Corium International, Inc Latest Developments
11.8 DURECT Corporation
11.8.1 DURECT Corporation Company Information
11.8.2 DURECT Corporation Transmucosal Drug Delivery Product Offered
11.8.3 DURECT Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 DURECT Corporation Main Business Overview
11.8.5 DURECT Corporation Latest Developments
11.9 Generex Biotechnology Corporation
11.9.1 Generex Biotechnology Corporation Company Information
11.9.2 Generex Biotechnology Corporation Transmucosal Drug Delivery Product Offered
11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Generex Biotechnology Corporation Main Business Overview
11.9.5 Generex Biotechnology Corporation Latest Developments
11.10 Inovio Pharmaceuticals, Inc.
11.10.1 Inovio Pharmaceuticals, Inc. Company Information
11.10.2 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offered
11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Inovio Pharmaceuticals, Inc. Main Business Overview
11.10.5 Inovio Pharmaceuticals, Inc. Latest Developments
11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Information
11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Offered
11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Main Business Overview
11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Latest Developments
11.12 MedPharm LTD
11.12.1 MedPharm LTD Company Information
11.12.2 MedPharm LTD Transmucosal Drug Delivery Product Offered
11.12.3 MedPharm LTD Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 MedPharm LTD Main Business Overview
11.12.5 MedPharm LTD Latest Developments
11.13 Mylan, Inc.
11.13.1 Mylan, Inc. Company Information
11.13.2 Mylan, Inc. Transmucosal Drug Delivery Product Offered
11.13.3 Mylan, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Mylan, Inc. Main Business Overview
11.13.5 Mylan, Inc. Latest Developments
11.14 Nemaura Pharma Ltd
11.14.1 Nemaura Pharma Ltd Company Information
11.14.2 Nemaura Pharma Ltd Transmucosal Drug Delivery Product Offered
11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Nemaura Pharma Ltd Main Business Overview
11.14.5 Nemaura Pharma Ltd Latest Developments
11.15 Nitto Denko Corporation
11.15.1 Nitto Denko Corporation Company Information
11.15.2 Nitto Denko Corporation Transmucosal Drug Delivery Product Offered
11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Nitto Denko Corporation Main Business Overview
11.15.5 Nitto Denko Corporation Latest Developments
11.16 Noven Pharmaceuticals, Inc.
11.16.1 Noven Pharmaceuticals, Inc. Company Information
11.16.2 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offered
11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Noven Pharmaceuticals, Inc. Main Business Overview
11.16.5 Noven Pharmaceuticals, Inc. Latest Developments
11.17 Pantec Biosolutions AG
11.17.1 Pantec Biosolutions AG Company Information
11.17.2 Pantec Biosolutions AG Transmucosal Drug Delivery Product Offered
11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Pantec Biosolutions AG Main Business Overview
11.17.5 Pantec Biosolutions AG Latest Developments
11.18 Tapemark
11.18.1 Tapemark Company Information
11.18.2 Tapemark Transmucosal Drug Delivery Product Offered
11.18.3 Tapemark Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Tapemark Main Business Overview
11.18.5 Tapemark Latest Developments
11.19 tesa Labtec GmbH
11.19.1 tesa Labtec GmbH Company Information
11.19.2 tesa Labtec GmbH Transmucosal Drug Delivery Product Offered
11.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 tesa Labtec GmbH Main Business Overview
11.19.5 tesa Labtec GmbH Latest Developments
11.20 TEVA Pharmaceutical Industries Ltd.
11.20.1 TEVA Pharmaceutical Industries Ltd. Company Information
11.20.2 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product Offered
11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 TEVA Pharmaceutical Industries Ltd. Main Business Overview
11.20.5 TEVA Pharmaceutical Industries Ltd. Latest Developments
11.21 Zosano Pharma
11.21.1 Zosano Pharma Company Information
11.21.2 Zosano Pharma Transmucosal Drug Delivery Product Offered
11.21.3 Zosano Pharma Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Zosano Pharma Main Business Overview
11.21.5 Zosano Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transmucosal Drug Delivery Market Size (2020-2031)
2.1.2 Transmucosal Drug Delivery Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Transmucosal Drug Delivery by Country/Region (2020, 2024 & 2031)
2.2 Transmucosal Drug Delivery Segment by Type
2.2.1 Passive Transdermal Drug Delivery
2.2.2 Active Transdermal Drug Delivery
2.3 Transmucosal Drug Delivery Market Size by Type
2.3.1 Transmucosal Drug Delivery Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Transmucosal Drug Delivery Market Size Market Share by Type (2020-2025)
2.4 Transmucosal Drug Delivery Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Transmucosal Drug Delivery Market Size by Application
2.5.1 Transmucosal Drug Delivery Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Transmucosal Drug Delivery Market Size Market Share by Application (2020-2025)
3 TRANSMUCOSAL DRUG DELIVERY MARKET SIZE BY PLAYER
3.1 Transmucosal Drug Delivery Market Size Market Share by Player
3.1.1 Global Transmucosal Drug Delivery Revenue by Player (2020-2025)
3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Player (2020-2025)
3.2 Global Transmucosal Drug Delivery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TRANSMUCOSAL DRUG DELIVERY BY REGION
4.1 Transmucosal Drug Delivery Market Size by Region (2020-2025)
4.2 Global Transmucosal Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transmucosal Drug Delivery Market Size Growth (2020-2025)
4.4 APAC Transmucosal Drug Delivery Market Size Growth (2020-2025)
4.5 Europe Transmucosal Drug Delivery Market Size Growth (2020-2025)
4.6 Middle East & Africa Transmucosal Drug Delivery Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Transmucosal Drug Delivery Market Size by Country (2020-2025)
5.2 Americas Transmucosal Drug Delivery Market Size by Type (2020-2025)
5.3 Americas Transmucosal Drug Delivery Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transmucosal Drug Delivery Market Size by Region (2020-2025)
6.2 APAC Transmucosal Drug Delivery Market Size by Type (2020-2025)
6.3 APAC Transmucosal Drug Delivery Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Transmucosal Drug Delivery Market Size by Country (2020-2025)
7.2 Europe Transmucosal Drug Delivery Market Size by Type (2020-2025)
7.3 Europe Transmucosal Drug Delivery Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transmucosal Drug Delivery by Region (2020-2025)
8.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2020-2025)
8.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET FORECAST
10.1 Global Transmucosal Drug Delivery Forecast by Region (2026-2031)
10.1.1 Global Transmucosal Drug Delivery Forecast by Region (2026-2031)
10.1.2 Americas Transmucosal Drug Delivery Forecast
10.1.3 APAC Transmucosal Drug Delivery Forecast
10.1.4 Europe Transmucosal Drug Delivery Forecast
10.1.5 Middle East & Africa Transmucosal Drug Delivery Forecast
10.2 Americas Transmucosal Drug Delivery Forecast by Country (2026-2031)
10.2.1 United States Market Transmucosal Drug Delivery Forecast
10.2.2 Canada Market Transmucosal Drug Delivery Forecast
10.2.3 Mexico Market Transmucosal Drug Delivery Forecast
10.2.4 Brazil Market Transmucosal Drug Delivery Forecast
10.3 APAC Transmucosal Drug Delivery Forecast by Region (2026-2031)
10.3.1 China Transmucosal Drug Delivery Market Forecast
10.3.2 Japan Market Transmucosal Drug Delivery Forecast
10.3.3 Korea Market Transmucosal Drug Delivery Forecast
10.3.4 Southeast Asia Market Transmucosal Drug Delivery Forecast
10.3.5 India Market Transmucosal Drug Delivery Forecast
10.3.6 Australia Market Transmucosal Drug Delivery Forecast
10.4 Europe Transmucosal Drug Delivery Forecast by Country (2026-2031)
10.4.1 Germany Market Transmucosal Drug Delivery Forecast
10.4.2 France Market Transmucosal Drug Delivery Forecast
10.4.3 UK Market Transmucosal Drug Delivery Forecast
10.4.4 Italy Market Transmucosal Drug Delivery Forecast
10.4.5 Russia Market Transmucosal Drug Delivery Forecast
10.5 Middle East & Africa Transmucosal Drug Delivery Forecast by Region (2026-2031)
10.5.1 Egypt Market Transmucosal Drug Delivery Forecast
10.5.2 South Africa Market Transmucosal Drug Delivery Forecast
10.5.3 Israel Market Transmucosal Drug Delivery Forecast
10.5.4 Turkey Market Transmucosal Drug Delivery Forecast
10.6 Global Transmucosal Drug Delivery Forecast by Type (2026-2031)
10.7 Global Transmucosal Drug Delivery Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Transmucosal Drug Delivery Forecast
11 KEY PLAYERS ANALYSIS
11.1 3M Pharmaceuticals
11.1.1 3M Pharmaceuticals Company Information
11.1.2 3M Pharmaceuticals Transmucosal Drug Delivery Product Offered
11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 3M Pharmaceuticals Main Business Overview
11.1.5 3M Pharmaceuticals Latest Developments
11.2 Acrux Limited
11.2.1 Acrux Limited Company Information
11.2.2 Acrux Limited Transmucosal Drug Delivery Product Offered
11.2.3 Acrux Limited Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Acrux Limited Main Business Overview
11.2.5 Acrux Limited Latest Developments
11.3 ALZA Corporation
11.3.1 ALZA Corporation Company Information
11.3.2 ALZA Corporation Transmucosal Drug Delivery Product Offered
11.3.3 ALZA Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 ALZA Corporation Main Business Overview
11.3.5 ALZA Corporation Latest Developments
11.4 Antares Pharma, Inc.
11.4.1 Antares Pharma, Inc. Company Information
11.4.2 Antares Pharma, Inc. Transmucosal Drug Delivery Product Offered
11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Antares Pharma, Inc. Main Business Overview
11.4.5 Antares Pharma, Inc. Latest Developments
11.5 Apricus BioSciences, Inc
11.5.1 Apricus BioSciences, Inc Company Information
11.5.2 Apricus BioSciences, Inc Transmucosal Drug Delivery Product Offered
11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Apricus BioSciences, Inc Main Business Overview
11.5.5 Apricus BioSciences, Inc Latest Developments
11.6 Aveva Drug Delivery Systems
11.6.1 Aveva Drug Delivery Systems Company Information
11.6.2 Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Offered
11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Aveva Drug Delivery Systems Main Business Overview
11.6.5 Aveva Drug Delivery Systems Latest Developments
11.7 Corium International, Inc
11.7.1 Corium International, Inc Company Information
11.7.2 Corium International, Inc Transmucosal Drug Delivery Product Offered
11.7.3 Corium International, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Corium International, Inc Main Business Overview
11.7.5 Corium International, Inc Latest Developments
11.8 DURECT Corporation
11.8.1 DURECT Corporation Company Information
11.8.2 DURECT Corporation Transmucosal Drug Delivery Product Offered
11.8.3 DURECT Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 DURECT Corporation Main Business Overview
11.8.5 DURECT Corporation Latest Developments
11.9 Generex Biotechnology Corporation
11.9.1 Generex Biotechnology Corporation Company Information
11.9.2 Generex Biotechnology Corporation Transmucosal Drug Delivery Product Offered
11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Generex Biotechnology Corporation Main Business Overview
11.9.5 Generex Biotechnology Corporation Latest Developments
11.10 Inovio Pharmaceuticals, Inc.
11.10.1 Inovio Pharmaceuticals, Inc. Company Information
11.10.2 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offered
11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Inovio Pharmaceuticals, Inc. Main Business Overview
11.10.5 Inovio Pharmaceuticals, Inc. Latest Developments
11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Information
11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Offered
11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Main Business Overview
11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Latest Developments
11.12 MedPharm LTD
11.12.1 MedPharm LTD Company Information
11.12.2 MedPharm LTD Transmucosal Drug Delivery Product Offered
11.12.3 MedPharm LTD Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 MedPharm LTD Main Business Overview
11.12.5 MedPharm LTD Latest Developments
11.13 Mylan, Inc.
11.13.1 Mylan, Inc. Company Information
11.13.2 Mylan, Inc. Transmucosal Drug Delivery Product Offered
11.13.3 Mylan, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Mylan, Inc. Main Business Overview
11.13.5 Mylan, Inc. Latest Developments
11.14 Nemaura Pharma Ltd
11.14.1 Nemaura Pharma Ltd Company Information
11.14.2 Nemaura Pharma Ltd Transmucosal Drug Delivery Product Offered
11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Nemaura Pharma Ltd Main Business Overview
11.14.5 Nemaura Pharma Ltd Latest Developments
11.15 Nitto Denko Corporation
11.15.1 Nitto Denko Corporation Company Information
11.15.2 Nitto Denko Corporation Transmucosal Drug Delivery Product Offered
11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Nitto Denko Corporation Main Business Overview
11.15.5 Nitto Denko Corporation Latest Developments
11.16 Noven Pharmaceuticals, Inc.
11.16.1 Noven Pharmaceuticals, Inc. Company Information
11.16.2 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offered
11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Noven Pharmaceuticals, Inc. Main Business Overview
11.16.5 Noven Pharmaceuticals, Inc. Latest Developments
11.17 Pantec Biosolutions AG
11.17.1 Pantec Biosolutions AG Company Information
11.17.2 Pantec Biosolutions AG Transmucosal Drug Delivery Product Offered
11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Pantec Biosolutions AG Main Business Overview
11.17.5 Pantec Biosolutions AG Latest Developments
11.18 Tapemark
11.18.1 Tapemark Company Information
11.18.2 Tapemark Transmucosal Drug Delivery Product Offered
11.18.3 Tapemark Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Tapemark Main Business Overview
11.18.5 Tapemark Latest Developments
11.19 tesa Labtec GmbH
11.19.1 tesa Labtec GmbH Company Information
11.19.2 tesa Labtec GmbH Transmucosal Drug Delivery Product Offered
11.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 tesa Labtec GmbH Main Business Overview
11.19.5 tesa Labtec GmbH Latest Developments
11.20 TEVA Pharmaceutical Industries Ltd.
11.20.1 TEVA Pharmaceutical Industries Ltd. Company Information
11.20.2 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product Offered
11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 TEVA Pharmaceutical Industries Ltd. Main Business Overview
11.20.5 TEVA Pharmaceutical Industries Ltd. Latest Developments
11.21 Zosano Pharma
11.21.1 Zosano Pharma Company Information
11.21.2 Zosano Pharma Transmucosal Drug Delivery Product Offered
11.21.3 Zosano Pharma Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Zosano Pharma Main Business Overview
11.21.5 Zosano Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vascular Endothelial Growth Factor B Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vascular Endothelial Growth Factor B Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Aflibercept
Table 4. Major Players of Aflibercept Biosimilar
Table 5. Major Players of CSL-346
Table 6. Major Players of Others
Table 7. Global Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 8. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Table 9. Global Vascular Endothelial Growth Factor B Revenue by Type (2020-2025) & ($ million)
Table 10. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2020-2025)
Table 11. Global Vascular Endothelial Growth Factor B Sale Price by Type (2020-2025) & (USD/Pcs)
Table 12. Global Vascular Endothelial Growth Factor B Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Vascular Endothelial Growth Factor B Sale Market Share by Application (2020-2025)
Table 14. Global Vascular Endothelial Growth Factor B Revenue by Application (2020-2025) & ($ million)
Table 15. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2020-2025)
Table 16. Global Vascular Endothelial Growth Factor B Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Vascular Endothelial Growth Factor B Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Vascular Endothelial Growth Factor B Sales Market Share by Company (2020-2025)
Table 19. Global Vascular Endothelial Growth Factor B Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Vascular Endothelial Growth Factor B Revenue Market Share by Company (2020-2025)
Table 21. Global Vascular Endothelial Growth Factor B Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Vascular Endothelial Growth Factor B Producing Area Distribution and Sales Area
Table 23. Players Vascular Endothelial Growth Factor B Products Offered
Table 24. Vascular Endothelial Growth Factor B Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Vascular Endothelial Growth Factor B Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Vascular Endothelial Growth Factor B Sales Market Share Geographic Region (2020-2025)
Table 29. Global Vascular Endothelial Growth Factor B Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Vascular Endothelial Growth Factor B Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Vascular Endothelial Growth Factor B Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Vascular Endothelial Growth Factor B Sales Market Share by Country/Region (2020-2025)
Table 33. Global Vascular Endothelial Growth Factor B Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Vascular Endothelial Growth Factor B Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Vascular Endothelial Growth Factor B Sales Market Share by Country (2020-2025)
Table 37. Americas Vascular Endothelial Growth Factor B Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 39. Americas Vascular Endothelial Growth Factor B Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Vascular Endothelial Growth Factor B Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Vascular Endothelial Growth Factor B Sales Market Share by Region (2020-2025)
Table 42. APAC Vascular Endothelial Growth Factor B Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 44. APAC Vascular Endothelial Growth Factor B Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Vascular Endothelial Growth Factor B Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 48. Europe Vascular Endothelial Growth Factor B Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Vascular Endothelial Growth Factor B
Table 54. Key Market Challenges & Risks of Vascular Endothelial Growth Factor B
Table 55. Key Industry Trends of Vascular Endothelial Growth Factor B
Table 56. Vascular Endothelial Growth Factor B Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Vascular Endothelial Growth Factor B Distributors List
Table 59. Vascular Endothelial Growth Factor B Customer List
Table 60. Global Vascular Endothelial Growth Factor B Sales Forecast by Region (2026-2031) & (K Pcs)
Table 61. Global Vascular Endothelial Growth Factor B Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Vascular Endothelial Growth Factor B Sales Forecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Vascular Endothelial Growth Factor B Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Vascular Endothelial Growth Factor B Sales Forecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Vascular Endothelial Growth Factor B Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Vascular Endothelial Growth Factor B Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Vascular Endothelial Growth Factor B Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Vascular Endothelial Growth Factor B Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Vascular Endothelial Growth Factor B Sales Forecast by Type (2026-2031) & (K Pcs)
Table 71. Global Vascular Endothelial Growth Factor B Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Vascular Endothelial Growth Factor B Sales Forecast by Application (2026-2031) & (K Pcs)
Table 73. Global Vascular Endothelial Growth Factor B Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Alteogen Inc Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 75. Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 76. Alteogen Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. Alteogen Inc Main Business
Table 78. Alteogen Inc Latest Developments
Table 79. CSL Ltd Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 80. CSL Ltd Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 81. CSL Ltd Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. CSL Ltd Main Business
Table 83. CSL Ltd Latest Developments
Table 84. Eli Lilly and Company Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 85. Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 86. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Eli Lilly and Company Main Business
Table 88. Eli Lilly and Company Latest Developments
Table 89. Formycon AG Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 90. Formycon AG Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 91. Formycon AG Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Formycon AG Main Business
Table 93. Formycon AG Latest Developments
Table 94. Regeneron Pharmaceuticals Inc Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 95. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 96. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Regeneron Pharmaceuticals Inc Main Business
Table 98. Regeneron Pharmaceuticals Inc Latest Developments
Table 1. Vascular Endothelial Growth Factor B Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vascular Endothelial Growth Factor B Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Aflibercept
Table 4. Major Players of Aflibercept Biosimilar
Table 5. Major Players of CSL-346
Table 6. Major Players of Others
Table 7. Global Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 8. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Table 9. Global Vascular Endothelial Growth Factor B Revenue by Type (2020-2025) & ($ million)
Table 10. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2020-2025)
Table 11. Global Vascular Endothelial Growth Factor B Sale Price by Type (2020-2025) & (USD/Pcs)
Table 12. Global Vascular Endothelial Growth Factor B Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Vascular Endothelial Growth Factor B Sale Market Share by Application (2020-2025)
Table 14. Global Vascular Endothelial Growth Factor B Revenue by Application (2020-2025) & ($ million)
Table 15. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2020-2025)
Table 16. Global Vascular Endothelial Growth Factor B Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Vascular Endothelial Growth Factor B Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Vascular Endothelial Growth Factor B Sales Market Share by Company (2020-2025)
Table 19. Global Vascular Endothelial Growth Factor B Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Vascular Endothelial Growth Factor B Revenue Market Share by Company (2020-2025)
Table 21. Global Vascular Endothelial Growth Factor B Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Vascular Endothelial Growth Factor B Producing Area Distribution and Sales Area
Table 23. Players Vascular Endothelial Growth Factor B Products Offered
Table 24. Vascular Endothelial Growth Factor B Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Vascular Endothelial Growth Factor B Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Vascular Endothelial Growth Factor B Sales Market Share Geographic Region (2020-2025)
Table 29. Global Vascular Endothelial Growth Factor B Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Vascular Endothelial Growth Factor B Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Vascular Endothelial Growth Factor B Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Vascular Endothelial Growth Factor B Sales Market Share by Country/Region (2020-2025)
Table 33. Global Vascular Endothelial Growth Factor B Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Vascular Endothelial Growth Factor B Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Vascular Endothelial Growth Factor B Sales Market Share by Country (2020-2025)
Table 37. Americas Vascular Endothelial Growth Factor B Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 39. Americas Vascular Endothelial Growth Factor B Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Vascular Endothelial Growth Factor B Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Vascular Endothelial Growth Factor B Sales Market Share by Region (2020-2025)
Table 42. APAC Vascular Endothelial Growth Factor B Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 44. APAC Vascular Endothelial Growth Factor B Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Vascular Endothelial Growth Factor B Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 48. Europe Vascular Endothelial Growth Factor B Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Type (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Vascular Endothelial Growth Factor B
Table 54. Key Market Challenges & Risks of Vascular Endothelial Growth Factor B
Table 55. Key Industry Trends of Vascular Endothelial Growth Factor B
Table 56. Vascular Endothelial Growth Factor B Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Vascular Endothelial Growth Factor B Distributors List
Table 59. Vascular Endothelial Growth Factor B Customer List
Table 60. Global Vascular Endothelial Growth Factor B Sales Forecast by Region (2026-2031) & (K Pcs)
Table 61. Global Vascular Endothelial Growth Factor B Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Vascular Endothelial Growth Factor B Sales Forecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Vascular Endothelial Growth Factor B Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Vascular Endothelial Growth Factor B Sales Forecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Vascular Endothelial Growth Factor B Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Vascular Endothelial Growth Factor B Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Vascular Endothelial Growth Factor B Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Vascular Endothelial Growth Factor B Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Vascular Endothelial Growth Factor B Sales Forecast by Type (2026-2031) & (K Pcs)
Table 71. Global Vascular Endothelial Growth Factor B Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Vascular Endothelial Growth Factor B Sales Forecast by Application (2026-2031) & (K Pcs)
Table 73. Global Vascular Endothelial Growth Factor B Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Alteogen Inc Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 75. Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 76. Alteogen Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. Alteogen Inc Main Business
Table 78. Alteogen Inc Latest Developments
Table 79. CSL Ltd Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 80. CSL Ltd Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 81. CSL Ltd Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. CSL Ltd Main Business
Table 83. CSL Ltd Latest Developments
Table 84. Eli Lilly and Company Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 85. Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 86. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Eli Lilly and Company Main Business
Table 88. Eli Lilly and Company Latest Developments
Table 89. Formycon AG Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 90. Formycon AG Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 91. Formycon AG Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Formycon AG Main Business
Table 93. Formycon AG Latest Developments
Table 94. Regeneron Pharmaceuticals Inc Basic Information, Vascular Endothelial Growth Factor B Manufacturing Base, Sales Area and Its Competitors
Table 95. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolios and Specifications
Table 96. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Regeneron Pharmaceuticals Inc Main Business
Table 98. Regeneron Pharmaceuticals Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vascular Endothelial Growth Factor B
Figure 2. Vascular Endothelial Growth Factor B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vascular Endothelial Growth Factor B Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Vascular Endothelial Growth Factor B Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vascular Endothelial Growth Factor B Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vascular Endothelial Growth Factor B Sales Market Share by Country/Region (2024)
Figure 10. Vascular Endothelial Growth Factor B Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Aflibercept
Figure 12. Product Picture of Aflibercept Biosimilar
Figure 13. Product Picture of CSL-346
Figure 14. Product Picture of Others
Figure 15. Global Vascular Endothelial Growth Factor B Sales Market Share by Type in 2025
Figure 16. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2020-2025)
Figure 17. Vascular Endothelial Growth Factor B Consumed in Rectal Cancer
Figure 18. Global Vascular Endothelial Growth Factor B Market: Rectal Cancer (2020-2025) & (K Pcs)
Figure 19. Vascular Endothelial Growth Factor B Consumed in Retinal Vein Occlusion
Figure 20. Global Vascular Endothelial Growth Factor B Market: Retinal Vein Occlusion (2020-2025) & (K Pcs)
Figure 21. Vascular Endothelial Growth Factor B Consumed in Diabetic Nephropathy
Figure 22. Global Vascular Endothelial Growth Factor B Market: Diabetic Nephropathy (2020-2025) & (K Pcs)
Figure 23. Vascular Endothelial Growth Factor B Consumed in Others
Figure 24. Global Vascular Endothelial Growth Factor B Market: Others (2020-2025) & (K Pcs)
Figure 25. Global Vascular Endothelial Growth Factor B Sale Market Share by Application (2024)
Figure 26. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application in 2025
Figure 27. Vascular Endothelial Growth Factor B Sales by Company in 2025 (K Pcs)
Figure 28. Global Vascular Endothelial Growth Factor B Sales Market Share by Company in 2025
Figure 29. Vascular Endothelial Growth Factor B Revenue by Company in 2025 ($ millions)
Figure 30. Global Vascular Endothelial Growth Factor B Revenue Market Share by Company in 2025
Figure 31. Global Vascular Endothelial Growth Factor B Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Vascular Endothelial Growth Factor B Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Vascular Endothelial Growth Factor B Sales 2020-2025 (K Pcs)
Figure 34. Americas Vascular Endothelial Growth Factor B Revenue 2020-2025 ($ millions)
Figure 35. APAC Vascular Endothelial Growth Factor B Sales 2020-2025 (K Pcs)
Figure 36. APAC Vascular Endothelial Growth Factor B Revenue 2020-2025 ($ millions)
Figure 37. Europe Vascular Endothelial Growth Factor B Sales 2020-2025 (K Pcs)
Figure 38. Europe Vascular Endothelial Growth Factor B Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Vascular Endothelial Growth Factor B Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Vascular Endothelial Growth Factor B Revenue 2020-2025 ($ millions)
Figure 41. Americas Vascular Endothelial Growth Factor B Sales Market Share by Country in 2025
Figure 42. Americas Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2025)
Figure 43. Americas Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Figure 44. Americas Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2025)
Figure 45. United States Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Vascular Endothelial Growth Factor B Sales Market Share by Region in 2025
Figure 50. APAC Vascular Endothelial Growth Factor B Revenue Market Share by Region (2020-2025)
Figure 51. APAC Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Figure 52. APAC Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2025)
Figure 53. China Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 57. India Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country in 2025
Figure 61. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2025)
Figure 62. Europe Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Figure 63. Europe Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2025)
Figure 64. Germany Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 65. France Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2025)
Figure 72. Egypt Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Vascular Endothelial Growth Factor B in 2025
Figure 78. Manufacturing Process Analysis of Vascular Endothelial Growth Factor B
Figure 79. Industry Chain Structure of Vascular Endothelial Growth Factor B
Figure 80. Channels of Distribution
Figure 81. Global Vascular Endothelial Growth Factor B Sales Market Forecast by Region (2026-2031)
Figure 82. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Vascular Endothelial Growth Factor B Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Vascular Endothelial Growth Factor B Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Vascular Endothelial Growth Factor B
Figure 2. Vascular Endothelial Growth Factor B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vascular Endothelial Growth Factor B Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Vascular Endothelial Growth Factor B Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vascular Endothelial Growth Factor B Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vascular Endothelial Growth Factor B Sales Market Share by Country/Region (2024)
Figure 10. Vascular Endothelial Growth Factor B Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Aflibercept
Figure 12. Product Picture of Aflibercept Biosimilar
Figure 13. Product Picture of CSL-346
Figure 14. Product Picture of Others
Figure 15. Global Vascular Endothelial Growth Factor B Sales Market Share by Type in 2025
Figure 16. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2020-2025)
Figure 17. Vascular Endothelial Growth Factor B Consumed in Rectal Cancer
Figure 18. Global Vascular Endothelial Growth Factor B Market: Rectal Cancer (2020-2025) & (K Pcs)
Figure 19. Vascular Endothelial Growth Factor B Consumed in Retinal Vein Occlusion
Figure 20. Global Vascular Endothelial Growth Factor B Market: Retinal Vein Occlusion (2020-2025) & (K Pcs)
Figure 21. Vascular Endothelial Growth Factor B Consumed in Diabetic Nephropathy
Figure 22. Global Vascular Endothelial Growth Factor B Market: Diabetic Nephropathy (2020-2025) & (K Pcs)
Figure 23. Vascular Endothelial Growth Factor B Consumed in Others
Figure 24. Global Vascular Endothelial Growth Factor B Market: Others (2020-2025) & (K Pcs)
Figure 25. Global Vascular Endothelial Growth Factor B Sale Market Share by Application (2024)
Figure 26. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application in 2025
Figure 27. Vascular Endothelial Growth Factor B Sales by Company in 2025 (K Pcs)
Figure 28. Global Vascular Endothelial Growth Factor B Sales Market Share by Company in 2025
Figure 29. Vascular Endothelial Growth Factor B Revenue by Company in 2025 ($ millions)
Figure 30. Global Vascular Endothelial Growth Factor B Revenue Market Share by Company in 2025
Figure 31. Global Vascular Endothelial Growth Factor B Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Vascular Endothelial Growth Factor B Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Vascular Endothelial Growth Factor B Sales 2020-2025 (K Pcs)
Figure 34. Americas Vascular Endothelial Growth Factor B Revenue 2020-2025 ($ millions)
Figure 35. APAC Vascular Endothelial Growth Factor B Sales 2020-2025 (K Pcs)
Figure 36. APAC Vascular Endothelial Growth Factor B Revenue 2020-2025 ($ millions)
Figure 37. Europe Vascular Endothelial Growth Factor B Sales 2020-2025 (K Pcs)
Figure 38. Europe Vascular Endothelial Growth Factor B Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Vascular Endothelial Growth Factor B Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Vascular Endothelial Growth Factor B Revenue 2020-2025 ($ millions)
Figure 41. Americas Vascular Endothelial Growth Factor B Sales Market Share by Country in 2025
Figure 42. Americas Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2025)
Figure 43. Americas Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Figure 44. Americas Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2025)
Figure 45. United States Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Vascular Endothelial Growth Factor B Sales Market Share by Region in 2025
Figure 50. APAC Vascular Endothelial Growth Factor B Revenue Market Share by Region (2020-2025)
Figure 51. APAC Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Figure 52. APAC Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2025)
Figure 53. China Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 57. India Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country in 2025
Figure 61. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country (2020-2025)
Figure 62. Europe Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Figure 63. Europe Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2025)
Figure 64. Germany Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 65. France Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Application (2020-2025)
Figure 72. Egypt Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Vascular Endothelial Growth Factor B Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Vascular Endothelial Growth Factor B in 2025
Figure 78. Manufacturing Process Analysis of Vascular Endothelial Growth Factor B
Figure 79. Industry Chain Structure of Vascular Endothelial Growth Factor B
Figure 80. Channels of Distribution
Figure 81. Global Vascular Endothelial Growth Factor B Sales Market Forecast by Region (2026-2031)
Figure 82. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Vascular Endothelial Growth Factor B Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Vascular Endothelial Growth Factor B Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Application (2026-2031)